What oral antibiotic is appropriate for a 65-year-old woman with a recent uncomplicated urinary tract infection treated with nitrofurantoin, whose Escherichia coli isolate is susceptible?

Recommended Antibiotic for Recurrent UTI with E. coli Susceptibility

Since the E. coli is confirmed susceptible and this is a recent recurrence after nitrofurantoin treatment, switch to trimethoprim-sulfamethoxazole (160/800 mg twice daily for 3 days) as your first choice, assuming local resistance rates are <20%. If TMP-SMX resistance exceeds 20% in your area or the patient has contraindications, use fosfomycin trometamol (3 g single dose) as an equally effective alternative 1.

Treatment Algorithm for This Clinical Scenario

Step 1: Verify susceptibility data

• You have confirmed E. coli susceptibility, which is critical since this guides definitive therapy
• The organism was susceptible to the previous nitrofurantoin treatment, but recurrence within 1 week suggests either treatment failure or reinfection 1

Step 2: Select appropriate antibiotic based on hierarchy

For a 65-year-old woman with recent UTI recurrence:

• First-line option: TMP-SMX (160/800 mg twice daily for 3 days)

  • Clinical cure rate: 90-100% when organism is susceptible 1
  • Bacterial cure rate: 91-100% 1
  • Critical caveat: Only use if local E. coli resistance is <20% 1
  • When organism is susceptible, cure rates reach 88% vs 54% with resistant strains 1

• Alternative first-line: Fosfomycin trometamol (3 g single dose)

  • Clinical cure rate: 91% 1
  • Bacterial cure rate: 78-80% (slightly lower than nitrofurantoin) 1
  • Advantage: Single dose, minimal resistance, excellent for patient compliance 1
  • Maintains 85-100% susceptibility rates globally 2, 3

Step 3: Avoid repeating nitrofurantoin immediately

• While nitrofurantoin remains highly effective (93% clinical cure, 88% bacterial cure) 1, the guidelines recommend switching to a different agent when symptoms recur within 2-4 weeks 4
• Nitrofurantoin should be reserved for 5-7 day courses, not repeated short-term 1

Key Clinical Considerations

Why not continue nitrofurantoin:

• Recurrence within 1 week suggests either inadequate duration (should have been 5-7 days, not shorter) or the need for a different mechanism of action 1, 4
• Retreatment guidelines specifically state to assume the organism may not be susceptible to the original agent and use another drug for 7 days 4

Why TMP-SMX is preferred when susceptible:

• Shorter 3-day course with equivalent efficacy to 5-day nitrofurantoin 1
• When susceptibility is confirmed, clinical cure reaches 84% vs 41% with resistant organisms (P<0.001) 1
• More cost-effective and better studied in this exact scenario 1

Why fosfomycin is an excellent alternative:

• Single-dose therapy improves compliance 1
• Maintains activity against 85-97% of E. coli strains, including many resistant to other agents 2, 3
• Minimal collateral damage to gut microbiome 5
• Recent data suggests it may be slightly less effective than 5-day nitrofurantoin for treatment (not prophylaxis), but still highly effective 5

Important Pitfalls to Avoid

Do NOT use fluoroquinolones (ciprofloxacin, levofloxacin) for simple cystitis, even though they're highly effective (90% cure rate) 1. They should be reserved for pyelonephritis or complicated UTIs due to collateral damage concerns and resistance preservation 1.

Do NOT use beta-lactams (amoxicillin-clavulanate, cephalexin) as first-line—they have inferior efficacy (82-89% bacterial cure) and more adverse effects compared to other options 1. Use only when other agents cannot be used 1.

Do NOT use amoxicillin or ampicillin alone—very high resistance rates worldwide make them inappropriate for empirical treatment 1.

For This Specific Patient

Given her age (65) and recent treatment failure, I would:

1. Prescribe TMP-SMX 160/800 mg twice daily for 3 days if local resistance <20% and no sulfa allergy 1
2. Alternative: Fosfomycin 3 g single dose if TMP-SMX contraindicated or local resistance >20% 1
3. Consider urine culture if symptoms don't resolve or recur again within 4 weeks 4
4. Evaluate for recurrent UTI risk factors if this becomes a pattern (≥3 UTIs/year or 2 in 6 months) 4

The evidence strongly supports switching antibiotics after early recurrence rather than repeating the same agent, with TMP-SMX or fosfomycin being the most appropriate choices when susceptibility is confirmed 1, 4.